Skip to main content

Table 2 Clinical and imaging finding in RTRs and nRTRs

From: COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome

 

Group

P

Transplant Pts

Non-transplant Pts

Count (n%)

Count (n%)

Chills

11 (47.8)

13 (32.5)

0.228

NauseaVomiting

5 (21.7)

13 (32.5)

0.363

Diarrhea

5 (21.7)

12 (30.0)

0.477

Hemoptysis

1 (4.3)

0 (0.0)

0.189

Myalgia

6 (26.1)

15 (37.5)

0.355

headache

7 (30.4)

9 (22.5)

0.486

Anosmia

5 (21.7)

3 (9.4)

0.185

Fever

17 (73.9)

28 (70.0)

0.741

Cough

17 (73.9)

34 (85.0)

0.281

Dyspnea

16 (69.6)

36 (90.0)

0.045

Total GGO

22 (95.7)

38 (95.0)

0.701

Only GGO

2 (8.7)

6 (15)

0.381

Total consolidation

19 (82.6)

34 (85.0)

0.534

GGO + crazy paving

2 (8.7)

0 (0)

0.130

Only consolidation

1 (4.3)

2 (5)

0.701

GGO + consolidation

11 (47.8)

15 (37.5)

0.423

GGO + crazy paving + consolidation

7 (30.4)

17 (42.5)

0.342

Crazy paving

9 (39.1)

17 (42.5)

0.794

Multifocal bilateral

22 (95.7)

36 (97.3)

0.624

Multifocal unilateral

1 (4.3)

1 (2.7)

0.624

Unifocal

0 (0.0)

0 (0.0)

-

Peripheral

16 (100.0)

36 (97.3)

0.698

Central

6 (37.5)

10 (27.0)

0.327

Reversedhalo

9 (39.1)

15 (44.1)

0.708

Linear opacities

9 (39.1)

17 (50.0)

0.419

Bronchiectasis

5 (21.7)

10 (29.4)

0.519

Pleural effusion

0 (0.0)

8 (23.5)

0.013

Pericardial effusion

2 (9.1)

4 (11.8)

0.560

Number of involved lobes

4.65 ± 0.70 (5.00 (5.00–5.00))

4.32 ± 1.04 (5.00 (4.00–5.00))

0.318

Total CT score

12.40 ± 5.87 (11.00 (8.00–18.00))

11.59 ± 6.09 (10.50 (7.00–17.00))

0.576